GCCL will be attending World Vaccine Congress 2026, taking place from March 30 to April 2, 2026, in Washington, D.C., USA,
where we will welcome global vaccine and biopharma partners at Booth 252.
World Vaccine Congress is one of the industry’s leading global events, bringing together vaccine developers, pharmaceutical and biotech companies,
researchers, and solution providers to discuss the latest trends and innovations shaping vaccine and therapeutic development.
GCCL is pleased to join this year’s event and connect with partners from across the industry.
During the congress, GCCL will showcase its integrated central lab, bioanalytical, and assay development capabilities
that support vaccine and therapeutic development throughout the clinical trial process.
Our team will be available to discuss how GCCL helps clients generate reliable data and advance their development programs through tailored laboratory services and collaborative scientific support.
In addition to exhibiting at Booth 252, GCCL will also present its latest research on the
development and optimization of an automated Focus Reduction Neutralization Test (FRNT) assay for evaluating RSV neutralizing antibody titers.
This research highlights GCCL’s ongoing efforts to strengthen analytical capabilities that
can support vaccine and therapeutic developers in immunogenicity assessment and related studies.
For attendees planning to join WVC 2026, we warmly invite you to schedule a meeting with our team in advance.
We look forward to exploring potential collaboration opportunities and sharing how GCCL can support your clinical development needs.
As Washington, D.C. welcomes visitors during cherry blossom season, we hope to meet many of our global partners there and have meaningful conversations throughout the event.
Event Information
Event: World Vaccine Congress 2026
Date: March 30–April 2, 2026
Location: Washington, D.C., USA
Booth: 252
Exhibitor Profile & Meeting Request
Please feel free to contact us!
GCCL is committed to being your most reliable clinical trial partner, delivering value and trust across every project.
Click the banner below to learn more about us!
> About GCCL > Newsroom > Company News